Picture EBD Group Global Partnering Four Events One Price 650x80
Organisation › Details

Foundation Medicine Inc. (FMI)

Foundation Medicine is a molecular information company dedicated to a transformation in cancer care in which treatment is informed by a deep understanding of the genomic changes that contribute to each patient's unique cancer. The company offers a full suite of comprehensive genomic profiling assays to identify the molecular alterations in a patient’s cancer and match them with relevant targeted therapies, immunotherapies and clinical trials. Foundation Medicine’s molecular information platform aims to improve day-to-day care for patients by serving the needs of clinicians, academic researchers and drug developers to help advance the science of molecular medicine in cancer. *


Period Start 2012-12-21 existent
  Group Roche (Group)
Products Industry cancer test
  Industry 2 pharmacogenomic/pharmacogenetic cancer test
Persons Person Perettie, Cindy (Roche 201902– CEO of Foundation Medicine before Roche/Genentech + Ivax + Élan)
  Person 2 Cox, Troy (Foundation Medicine 201806 CEO before UCB 200804 President CNS Operations)
Region Region Cambridge, MA
  Country United States (USA)
  Street One Kendall Square
Suite B3501
  City 02139 Cambridge, MA
  Tel +1-617-418-2200
    Address record changed: 2020-12-02
Basic data Employees n. a.
    * Document for �About Section�: Foundation Medicine, Inc.. (1/7/19). "Press Release: Foundation Medicine Announces Executive Leadership Transition". Cambridge, MA.
Record changed: 2020-11-26


Picture [iito] Plain Stupid Simple 650x80px

More documents for Roche (Group)

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]


Picture EBD Group ChinaBio Partnerting Forum 2021 651x80

» top